Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries SciSparc Ltd. - Ordinary Shares (NQ: SPRC ) 0.7296 +0.0211 (+2.98%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about SciSparc Ltd. - Ordinary Shares < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression April 21, 2023 From Clearmind Medicine Inc. Via GlobeNewswire SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression April 21, 2023 From SciSparc Ltd Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 11, 2023 We're starting off the day with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on Tuesday! Via InvestorPlace Update: SciSparc To Spin Off Pharmaceutical Activities Into New Subsidiary March 01, 2023 The jury is out on how well SciSparc will do in executing its restructuring plan, but the company has no other choice. Via Talk Markets Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 11, 2023 Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear. Via Benzinga SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome April 04, 2023 From SciSparc Ltd Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday March 31, 2023 On Friday, 93 stocks made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 28, 2023 During Tuesday, 95 stocks hit new 52-week lows. Via Benzinga SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million March 28, 2023 From SciSparc Ltd Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday March 27, 2023 Welcome back and get ready for another day of trading with a breakdown of the biggest pre-market stock movers for Monday! Via InvestorPlace SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification March 10, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc Receives Approval to conduct its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome March 09, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc Completes Production Of Its Dronabinol-Based Drug Candidate For Its Clinical Trial On Tourette Syndrome March 06, 2023 SciSparc Ltd. (NASDAQ: SPRC) has successfully manufactured clinical batches of its drug candidate SCI-110 to be used in its upcoming multinational, multicenter, phase IIb trial for Tourette syndrome. Via Benzinga SciSparc Successfully Completed Production of its Proprietary Drug Candidate SCI-110 for its Upcoming Clinical Trial On Tourette Syndrome March 06, 2023 From SciSparc Ltd Via GlobeNewswire Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More February 27, 2023 Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and... Via Benzinga SciSparc's CBD-Based Drug One Step Closer To Clinical Trial On Children With Autism Spectrum Disorder February 27, 2023 SciSparc Ltd. (NASDAQ: SPRC) has signed an agreement with Israel's manufacturer and distributor of cannabis-based products, Tikun Olam Cannbit Pharmaceuticals Ltd., Israel (TASE:TKUN), to supply... Via Benzinga SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder February 27, 2023 From SciSparc Ltd Via GlobeNewswire Jeffs' Brands To Acquire A 49% Interest In A Company That Owns A Top Seller Brand On Amazon For $2.5M February 23, 2023 Jeffs' Brands Ltd (NASDAQ: JFBR), a data-driven e-commerce company operating on the Amazon Marketplace, has entered into a definitive agreement with SciSparc Ltd. Via Benzinga Jeffs' Brands Entered into a Definitive Agreement to Acquire a 49% interest in a company that Owns Wellution, a Top Seller Brand on Amazon for $2.5 million February 23, 2023 From Jeffs' Brands Ltd Via GlobeNewswire SciSparc Signs a Definitive Agreement to Sell 49% interest in its Subsidiary that Owns Wellution for $2.5 million February 23, 2023 From SciSparc Ltd Via GlobeNewswire SciSparc And Clearmind Reveal Three Unique Combinations Of Future Psychedelic-Based Compounds February 22, 2023 SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced that as part of its... Via Benzinga SciSparc and Clearmind Reveal Three Unique Combinations of Future Psychedelic-Based Compounds February 22, 2023 Clearmind Medicine submitted patent applications to protect the novel compounds From SciSparc Ltd Via GlobeNewswire Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of Future Psychedelic-Based Compounds February 22, 2023 From Clearmind Medicine Inc. Via GlobeNewswire Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 21, 2023 Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023. Via Benzinga Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket February 21, 2023 Gainers Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday. Via Benzinga Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session February 17, 2023 Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. Via Benzinga Why SciSparc Shares Are Moving During Friday's Session February 17, 2023 SciSparc Ltd (NASDAQ: SPRC) shares are trading higher by 8.08% to $0.98 Friday morning, though off the session high of $1.33, after the company announced its MitoCareX Bio joint venture achieved... Via Benzinga Why Is SciSparc (SPRC) Stock Up 14% Today? February 17, 2023 SciSparc (SPRC) stock is taking off on Friday as investors react to an update on its drug development joint venture MitoCareX Bio. Via InvestorPlace SciSparc's Drug Discovery Joint Venture MitoCareX Bio Successfully Reached First Milestone for its Future Machine Learning System February 17, 2023 From SciSparc Ltd Via GlobeNewswire Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US February 15, 2023 Israeli-based next-gen psychedelics biotech Clearmind Medicine (NASDAQ: CMND) together with partner clinical-stage pharma company SciSparc (NASDAQ: SPRC) has filed three provisional patent applications... Via Benzinga < Previous 1 2 ... 5 6 7 8 9 10 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.